NASDAQ: CJMB
Callan Jmb Inc Stock

$0.82+0.04 (+5.13%)
Updated Jun 12, 2026
CJMB Price
$0.82
Fair Value Price
$0.12
Market Cap
$4.64M
52 Week Low
$0.65
52 Week High
$5.88
P/E
-0.4x
P/B
2.9x
P/S
1.27x
PEG
N/A
Dividend Yield
N/A
Revenue
$5.38M
Earnings
-$9.94M
Gross Margin
35.7%
Operating Margin
-184.79%
Profit Margin
-184.7%
Debt to Equity
2.57
Operating Cash Flow
-$5M
Beta
0.8
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CJMB Overview

Callan JMB Inc., operating primarily through its subsidiary Coldchain Technology Services, LLC, specializes in providing temperature-controlled logistics solutions specifically for the life sciences sector. The company's services include comprehensive frozen shipping capabilities essential for a wide range of sensitive biological and medical materials. These critical shipments encompass items such as personalized medicines, cell-based therapies, stem cells, cell lines, vaccines, diagnostic samples, reproductive materials (including semen, eggs, and embryos), cord blood, organs, biopharmaceutical products, infectious substances, and other vital commodities. Additionally, Callan JMB Inc. offers packaging services for other perishable (non-pharmaceutical) client goods, alongside technical support. The company was founded in 2006 and is based in Spring Branch, Texas.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CJMB's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Logistic

Industry Rating
A
CJMB
Ranked
Unranked of 17

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$17.32A
$338.31A
$22.83B
View Top Logistic Stocks

Be the first to know about important CJMB news, forecast changes, insider trades & much more!

CJMB News

Overview

Due Diligence Score

Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CJMB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CJMB ($0.82) is overvalued by 568.28% relative to our estimate of its Fair Value price of $0.12 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CJMB ($0.82) is not significantly undervalued (568.28%) relative to our estimate of its Fair Value price of $0.12 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CJMB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CJMB due diligence checks available for Premium users.

Valuation

CJMB fair value

Fair Value of CJMB stock based on Discounted Cash Flow (DCF)

Price
$0.82
Fair Value
$0.12
Overvalued by
567.47%
CJMB ($0.82) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CJMB ($0.82) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CJMB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CJMB price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.4x
Industry
24.09x
Market
14.15x

CJMB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
2.9x
Industry
4.2x
CJMB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CJMB's financial health

Profit margin

Revenue
$1.1M
Net Income
-$3.2M
Profit Margin
-290.7%
CJMB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CJMB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$5.7M
Liabilities
$4.1M
Debt to equity
2.57
CJMB's short-term assets ($3.03M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CJMB's short-term assets ($3.03M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CJMB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.7M
Investing
-$35.3k
Financing
$1.0M
CJMB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CJMB vs Logistic Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CJMB$4.64M+5.26%-0.40x2.90x
ATXG$3.61M-1.81%-0.36x0.17x
GVH$5.71M-9.33%2.32x0.57x
SGLY$2.56M-3.57%-0.20x0.28x
HXHX$6.78M-5.68%1.88x0.25x

Callan Jmb Stock FAQ

What is Callan Jmb's quote symbol?

(NASDAQ: CJMB) Callan Jmb trades on the NASDAQ under the ticker symbol CJMB. Callan Jmb stock quotes can also be displayed as NASDAQ: CJMB.

If you're new to stock investing, here's how to buy Callan Jmb stock.

What is the 52 week high and low for Callan Jmb (NASDAQ: CJMB)?

(NASDAQ: CJMB) Callan Jmb's 52-week high was $5.88, and its 52-week low was $0.65. It is currently -86.04% from its 52-week high and 26.31% from its 52-week low.

How much is Callan Jmb stock worth today?

(NASDAQ: CJMB) Callan Jmb currently has 5,646,118 outstanding shares. With Callan Jmb stock trading at $0.82 per share, the total value of Callan Jmb stock (market capitalization) is $4.64M.

Callan Jmb stock was originally listed at a price of $4.10 in Feb 5, 2025. If you had invested in Callan Jmb stock at $4.10, your return over the last year would have been -79.98% (not including any dividends or dividend reinvestments).

How much is Callan Jmb's stock price per share?

(NASDAQ: CJMB) Callan Jmb stock price per share is $0.82 today (as of Jun 12, 2026).

What is Callan Jmb's Market Cap?

(NASDAQ: CJMB) Callan Jmb's market cap is $4.64M, as of Jun 14, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Callan Jmb's market cap is calculated by multiplying CJMB's current stock price of $0.82 by CJMB's total outstanding shares of 5,646,118.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.